Cell Cycle Regulatory Protein Expression Profiles by Adenovirus p53 Infection in Human Papilloma Virus-associated Cervical Cancer Cells.
- Author:
Yong Seok LEE
1
;
Su Mi BAE
;
Sun Young KWAK
;
Dong Chun PARK
;
Yong Wook KIM
;
Soo Young HUR
;
Eun Kyung PARK
;
Byoung Don HAN
;
Young Joo LEE
;
Chong Kook KIM
;
Do Kang KIM
;
Woong Shick AHN
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Korea. ahnws@ catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Adenoviral p53;
Cervical cancer;
Growth arrest;
Apoptosis;
Gene therapy
- MeSH:
Adenoviridae*;
Apoptosis;
Blotting, Western;
Cell Count;
Cell Cycle Checkpoints;
Cell Cycle*;
Cell Line;
G1 Phase;
Genes, Tumor Suppressor;
Genetic Therapy;
HeLa Cells;
Humans*;
Ovarian Neoplasms;
Papilloma*;
Proliferating Cell Nuclear Antigen;
Transcriptome;
Uterine Cervical Neoplasms*
- From:Cancer Research and Treatment
2006;38(3):168-177
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The tumor suppressor gene, p53, has been established as an essential component for the suppression of tumor cell growth. In this study, we investigated the time-course anticancer effects of adenoviral p53 (Adp53) infection on human ovarian cancer cells to provide insight into the molecular-level understanding of the growth suppression mechanisms involved in Adp53-mediated apoptosis and cell cycle arrest. MATERIALS AND METHODS: Three human cervical cancer cell lines (SiHa, CaSki, HeLa and HT3) were used. The effect of Adp53 infection was studied via cell count assay, cell cycle analysis, FACS, Western blot and macroarray assay. RESULTS: Adp53 exerts a significant role in suppressing cervical cancer cell growth. Adp53 also showed growth inhibitory effects in each cell line, and it induced apoptosis and cell cycle arrest. Adp53 differentially regulated the expression of genes and proteins, and the gene expression profiles in the SiHa cells revealed that the p21, p53 and mdm2 expressions were significantly up-regulated at 24 and 48 hr. Western blot shows that the p21 and p53 expressionlevels were significantly increased after Adp53 infection. In addition, in all cell lines, both the CDK4 and PCNA protein expression levels were decreased 48 h after Adp53 infection. Cell cycle arrest at the G1 phase was induced only in the SiHa and HeLa cells, suggesting that exogenous infection of Adp53 in cancer cells was significantly different from the other HPV-associated cervical cancer cells. CONCLUSION: Adp53 can inhibit cervical cancer cell growth through induction of apoptosis and cell cycle arrest, as well as through the regulation of the cell cycle-related proteins. The Adp53-mediated apoptosis can be employed as an advanced strategy for developing preferential tumor cell-specific delivery.
